SEC INSIDER TRANSACTIONS

PFIZER INC (PFE) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

PFE · PFIZER INC

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Stale snapshot · Covered: filings 2026-10-15 to 2026-11-13 · 2 filings · fetched 2026-11-13T19:20:20Z

View six-calendar-month insider history →

Recent reported activity

0purchase rows on this page

0sale rows on this page

2matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-10-30Filed 2026-11-03	BOURLA ALBERTDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each unit represents one phantom share of common stock. F2 These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. References: F1, F2	A Award / grantPhantom Stock Units SSP · Derivative	20A	30.52	Direct	Form 4 ↗0001225208-26-008592
2026-10-15Filed 2026-10-16	BOURLA ALBERTDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each unit represents one phantom share of common stock. F2 These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. References: F1, F2	A Award / grantPhantom Stock Units SSP · Derivative	20A	29.44	Direct	Form 4 ↗0001225208-26-008439

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.